CLDX
Celldex Therapeutics Inc
31.70$
-1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| 2,201.2% | 0.1% | 1,681.4% | 652.9% | 558.5% | 678.9% | 537.7% | 776.3% | 1,266.5% | 578.6% | 782.5% | 1,409.9% | 2,033.2% | 1,165.6% | 428.7% | 4,112.3% | 1,603.0% | 275.4% | 1,856.9% | 355.1% | 8,860.8% | 4,394.6% | 9,802.3% | 12,718.4% | 5,300.2% | 1,419.7% | 2,771.3% | 9,795.5% | 50.6% | 736.5% | 496.8% | 31.9% | 1,418.5% | 69.7% | 7,570.4% | 7,424.1% | – | – | 5,693.3% | – | – | |
| -2,101.2% | 99.9% | -1,581.4% | -552.9% | -458.5% | -578.9% | -437.7% | -676.3% | -1,166.5% | -478.6% | -682.5% | -1,309.9% | -1,933.2% | -1,065.6% | -328.7% | -4,012.3% | -1,503.0% | -175.4% | -1,756.9% | -255.1% | -8,760.8% | -4,294.6% | -9,702.3% | -12,618.4% | -5,200.2% | -1,319.7% | -2,671.3% | -9,695.5% | 49.4% | -636.5% | -396.8% | 68.1% | -1,318.5% | 30.3% | -7,470.4% | -7,324.1% | – | 100.0% | -5,593.3% | 100.0% | -56,850.9% | |
| 1,126.5% | 1,310.5% | 1,681.4% | 652.9% | 558.5% | 678.9% | 537.7% | 776.3% | 1,266.5% | 635.3% | 782.5% | 1,409.9% | 2,033.2% | 1,165.6% | 428.7% | 5,595.3% | 1,603.0% | 751.0% | 1,856.9% | 355.1% | 11,148.4% | 4,394.6% | 9,802.3% | 12,718.4% | 5,300.2% | 1,419.7% | 2,771.3% | 9,795.5% | 2,276.5% | 736.5% | 19,798.7% | 1,556.8% | 1,418.5% | 3,925.1% | 7,570.4% | 7,424.1% | – | 100,478.7% | 486,673.3% | 307,040.9% | 248,964.3% | |
| 313.1% | 636.8% | 471.3% | 170.6% | 136.2% | 170.5% | 137.5% | 203.4% | 395.5% | 245.6% | 343.6% | 546.6% | 623.3% | 362.9% | 134.4% | 1,494.9% | 544.9% | 95.7% | 601.6% | 123.7% | 3,804.6% | 1,868.6% | 3,971.8% | 4,389.0% | 1,604.7% | 409.1% | 686.7% | 2,694.4% | 541.9% | 213.8% | 5,835.3% | 365.4% | 315.1% | 873.4% | 1,556.8% | 1,423.4% | – | 15,870.7% | 76,326.7% | 59,559.1% | 42,090.2% | |
| 324.5% | 1,959.8% | 707.5% | 202.6% | 356.0% | 159.7% | 3,041.9% | -65.6% | -341.4% | 208.6% | 576.5% | 404.3% | 236.1% | 398.8% | 143.0% | 803.4% | 644.0% | 479.3% | 672.1% | 131.1% | 4,849.7% | 1,795.2% | 3,663.8% | 9,710.4% | 1,604.7% | 409.1% | 686.7% | 2,694.4% | 2,767.9% | 516.4% | 25,634.0% | 1,922.3% | 315.1% | 4,798.6% | 1,556.8% | 1,423.4% | – | 116,349.3% | 557,306.7% | 366,568.2% | 234,097.3% | |
| -1,351.0% | -1,859.8% | -2,288.9% | -755.5% | -814.5% | -738.6% | -2,941.9% | -610.7% | -825.1% | -687.2% | -1,259.0% | -1,714.3% | -2,169.2% | -1,464.4% | -471.7% | -4,815.7% | -2,147.0% | -654.7% | -2,429.1% | -386.2% | -13,610.5% | -6,089.8% | -13,366.1% | -22,328.8% | -6,804.9% | -1,728.8% | -3,357.9% | -12,389.9% | -2,718.5% | -1,152.9% | -26,030.8% | -1,854.2% | -1,633.5% | -4,768.3% | -9,027.2% | -8,747.5% | – | -116,249.3% | -562,900.0% | -366,468.2% | -290,948.2% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 407.8% | 185.4% | 4,684.0% | 0.0% | 0.0% | 10,801.9% | – | – | – | – | – | 1,472.9% | – | 664.5% | – | – | 1,900.7% | 57.5% | 119.0% | 240.5% | 224.1% | 86.7% | 321.6% | – | – | 75.3% | – | – | – | – | – | – | – | – | – | – | – | |
| -1,333.2% | -1,724.0% | -2,233.4% | -746.0% | -804.4% | -663.3% | -2,922.7% | -593.8% | -769.7% | -533.0% | -1,209.8% | -1,647.4% | -2,090.3% | -1,177.8% | -462.8% | -4,770.8% | -2,129.3% | -603.4% | -2,414.3% | -384.3% | -13,515.7% | -6,032.3% | -13,247.1% | -22,088.3% | -6,580.8% | -1,642.1% | -3,036.3% | -11,381.3% | -2,522.1% | -1,048.3% | -21,030.8% | -1,434.8% | -1,320.0% | -4,007.8% | -7,740.4% | -7,753.4% | – | -108,480.0% | -524,566.7% | -334,104.5% | -268,385.7% | |
| -35.6% | -271.6% | 332.3% | 33.3% | -132.5% | -552.1% | -18.8% | -571.8% | -1,584.7% | -495.8% | 367.3% | -418.2% | -932.2% | -501.5% | -0.6% | -96.6% | 162.9% | -24.8% | 111.5% | 11.0% | -148.4% | -261.7% | -854.0% | 10,162.0% | -224.1% | -173.3% | -718.3% | -1,290.7% | -196.4% | 324.0% | 469.1% | – | – | – | – | – | – | – | – | – | – | |
| -1,333.2% | -1,724.0% | -2,233.4% | -746.0% | -671.8% | -111.1% | -2,903.9% | -593.8% | -769.7% | -533.0% | -1,209.8% | -1,647.4% | -2,090.3% | -1,177.8% | -462.8% | -4,674.2% | -2,129.3% | -578.6% | -2,414.3% | -384.3% | -13,367.3% | -6,032.3% | -13,247.1% | -22,088.3% | -6,580.8% | -1,642.1% | -3,036.3% | -11,381.3% | -2,522.1% | -1,048.3% | -21,030.8% | -1,434.8% | -1,320.0% | -4,007.8% | -7,740.4% | -7,753.4% | – | -108,480.0% | -524,566.7% | -334,104.5% | -268,385.7% | |
| -1,308.1% | -1,566.4% | -1,963.6% | -697.4% | -568.6% | -719.9% | -550.0% | -843.8% | -1,473.3% | -740.0% | -931.2% | -1,695.2% | -2,335.2% | -1,299.4% | -420.4% | -5,020.8% | -1,919.0% | -251.2% | -2,245.4% | -356.8% | -12,073.9% | -5,930.5% | -13,208.0% | -16,552.8% | -6,416.0% | -1,600.4% | -2,961.2% | -11,099.3% | -2,471.5% | -832.0% | -20,534.0% | -1,402.9% | -1,295.4% | -3,938.1% | -7,615.7% | -7,633.8% | – | -107,392.0% | -518,873.3% | -330,004.5% | -265,353.6% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.